Literature DB >> 35557582

Prediction of early recurrence of hepatocellular carcinoma after resection based on Gd-EOB-DTPA enhanced magnetic resonance imaging: a preliminary study.

Qi-Yu Zhao1, Shi-Shun Liu2, Ming-Xin Fan3.   

Abstract

Background: Early recurrence (ER) after radical resection of hepatocellular carcinoma (HCC) affects the prognosis of patients. Gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) can improve the detection rate of small HCC. This study innovatively introduces a new quantitative index combined with qualitative index to compare the differences in clinical and imaging characteristics between ER and non-ER groups and evaluate the feasibility of Gd-EOB-DTPA-enhanced MRI in predicting ER.
Methods: A total of 68 patients with HCC confirmed by operation and pathology in the Shandong Cancer Hospital and Institute were included retrospectively. All participants were examined by Gd-EOB-DTPA-enhanced MRI within 3 weeks before surgery. Regular follow-up was performed every 2 months within 1 year after operation. Among them, 18 cases with new lesions were in ER group, and 50 cases without new lesions were in non-ER group. The clinical and imaging data of the 2 groups were collected, and the differences of clinical data and preoperative MRI signs between the ER group and non-ER group were compared. The predictive factors of ER after HCC were analyzed by multivariate logistic regression.
Results: The quantitative parameter lesion-to-liver contrast enhancement ratio (LLCER) can predict the pathological grade of HCC (P=0.023). The results of univariate analysis between the ER group and non-ER group showed that there were significant differences in pathological grade (P=0.008), lesion morphology (P=0.011), peritumoral low signal intensity in hepatobiliary phase (HBP) (P<0.001), satellite nodules (P<0.001), and LLCER (P<0.001) between the 2 groups. Multivariate logistic regression analysis showed that HBP peritumoral low signal intensity [odds ratio (OR) =7.214, 95% confidence interval (CI): 1.230-42.312, P=0.029], satellite nodules (OR =9.198, 95% CI: 1.402-60.339, P=0.021), and parameter LLCER value (OR =0.906, 95% CI: 0.826-0.995, P=0.039) were independent predictors of ER of HCC after resection. Conclusions: Preoperative Gd-EOB-DTPA enhanced MRI has important predictive value for early recurrence after radical resection of hepatocellular carcinoma. 2022 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); early recurrence; gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid (Gd-EOB-DTPA); magnetic resonance imaging (MRI); prediction

Year:  2022        PMID: 35557582      PMCID: PMC9086065          DOI: 10.21037/jgo-22-224

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  30 in total

1.  Reply to correspondence concerning: "Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection".

Authors:  Giovanni Marasco; Antonio Colecchia; Agostino Colli; Federico Ravaioli; Giovanni Casazza; Maria Letizia Bacchi Reggiani; Alessandro Cucchetti; Matteo Cescon; Davide Festi
Journal:  J Hepatol       Date:  2019-01-17       Impact factor: 25.083

2.  Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.

Authors:  Jingbiao Chen; Jing Zhou; Sichi Kuang; Yao Zhang; Sidong Xie; Bingjun He; Ying Deng; Hao Yang; Qungang Shan; Jun Wu; Claude B Sirlin; Jin Wang
Journal:  AJR Am J Roentgenol       Date:  2019-05-23       Impact factor: 3.959

3.  Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.

Authors:  Ying Zhao; Jingjun Wu; Qinhe Zhang; Zhengyu Hua; Wenjing Qi; Nan Wang; Tao Lin; Liuji Sheng; Dahua Cui; Jinghong Liu; Qingwei Song; Xin Li; Tingfan Wu; Yan Guo; Jingjing Cui; Ailian Liu
Journal:  J Magn Reson Imaging       Date:  2020-11-20       Impact factor: 4.813

4.  Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.

Authors:  Marion Roux; Frederic Pigneur; Julien Calderaro; Laurence Baranes; Mélanie Chiaradia; Lambros Tselikas; Thomas Decaens; Charlotte Costentin; Alexis Laurent; Daniel Azoulay; Ariane Mallat; Elie-Serge Zafrani; Alain Rahmouni; Alain Luciani
Journal:  J Magn Reson Imaging       Date:  2015-04-06       Impact factor: 4.813

5.  Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.

Authors:  Jordi Rimola; Alejandro Forner; Víctor Sapena; Neus Llarch; Anna Darnell; Alba Díaz; Angeles García-Criado; Lluís Bianchi; Ramon Vilana; Álvaro Díaz-González; Carmen Ayuso; Jordi Bruix; María Reig
Journal:  Eur Radiol       Date:  2019-08-01       Impact factor: 5.315

6.  Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker.

Authors:  Jin Woo Choi; Jeong Min Lee; Soo Jin Kim; Jeong-Hee Yoon; Jee Hyun Baek; Joon Koo Han; Byung Ihn Choi
Journal:  Radiology       Date:  2013-02-11       Impact factor: 11.105

7.  The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma.

Authors:  Li-Li Wang; Jun-Feng Li; Jun-Qiang Lei; Shun-Lin Guo; Jin-Kui Li; Yong-Sheng Xu; Yu Dou
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

8.  Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.

Authors:  Yi-Chen Chou; I-Ha Lao; Pei-Ling Hsieh; Ying-Ying Su; Chee-Wai Mak; Ding-Ping Sun; Ming-Jen Sheu; Hsing-Tao Kuo; Tzu-Ju Chen; Chung-Han Ho; Yu-Ting Kuo
Journal:  World J Gastroenterol       Date:  2019-06-07       Impact factor: 5.742

9.  Hepatocellular carcinoma grading and recurrence prediction using T1 mapping on gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.

Authors:  Xiali Qin; Tengfei Yang; Zhongkui Huang; Liling Long; Zhipeng Zhou; Wenmei Li; Yinjuan Gao; Mengzhu Wang; Xiaoyong Zhang
Journal:  Oncol Lett       Date:  2019-07-04       Impact factor: 2.967

10.  Spleen Radiomics Signature: A Potential Biomarker for Prediction of Early and Late Recurrences of Hepatocellular Carcinoma After Resection.

Authors:  Pinxiong Li; Lei Wu; Zhenhui Li; Jiao Li; Weitao Ye; Zhenwei Shi; Zeyan Xu; Chao Zhu; Huifen Ye; Zaiyi Liu; Changhong Liang
Journal:  Front Oncol       Date:  2021-08-13       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.